Västra Frölunda, Sweden

Magnus Björsne


Average Co-Inventor Count = 6.6

ph-index = 2

Forward Citations = 4(Granted Patents)


Location History:

  • Mölndal, SE (2006)
  • Västra Frölunda, SE (2005 - 2010)

Company Filing History:


Years Active: 2005-2010

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Magnus Björsne

Introduction

Magnus Björsne is a notable inventor based in Västra Frölunda, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cardiac arrhythmias. With a total of 4 patents to his name, his work continues to impact the medical community.

Latest Patents

Among his latest patents are the Oxabispidine compounds, which are useful in the treatment of cardiac arrhythmias. These compounds are designed to provide prophylaxis and treatment for both atrial and ventricular arrhythmias. The specific formula I, as described in his patents, includes various components that play a crucial role in their effectiveness.

Career Highlights

Magnus Björsne is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on innovative solutions for complex health issues, particularly in cardiology.

Collaborations

Throughout his career, Magnus has collaborated with esteemed colleagues such as Gert Strandlund and Kurt-Jürgen Hoffmann. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking medical treatments.

Conclusion

Magnus Björsne's contributions to the field of medicine through his patents and collaborations highlight his dedication to improving patient care. His work continues to pave the way for advancements in the treatment of cardiac conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…